(Q40563626)

English

Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures

scientific article published on November 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures (English)

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

platelet aggregation

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Takallapalli Ramesh Kumar Rao

1

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

P Rani Usha

2

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

M U R Naidu

3

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

J A Gogtay

4

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Matthew Meena

5

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

publication date

1 November 2003

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Current Therapeutic Research

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

64

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

9

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

685-696

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

22 September 2017

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

22 September 2017

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

22 September 2017

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

22 September 2017

Antiplatelet drugs. A comparative review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

22 September 2017

Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

22 September 2017

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

22 September 2017

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

22 September 2017

ADP receptors on platelets and ADP-selective antiaggregating agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

25 September 2017

Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

17 June 2018

ADP metabolism in vascular tissue, a possible thrombo-regulatory mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

17 June 2018

Single-dose pharmacodynamics of clopidogrel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

20 August 2018

ADP plays a key role in thrombogenesis in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053054

4 November 2018

Repeated-dose pharmacodynamics of clopidogrel in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.CURTHERES.2003.09.014

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40563626&oldid=2144254853"